Work

[P1–074]: PRECLINICAL DISCOVERY AND DEVELOPMENT OF MEDI1814, A MONOCLONAL ANTIBODY SELECTIVELY TARGETING BETA‐AMYLOID 42 (Aβ42)

Year: 2017

Type: article

Source: Alzheimer s & Dementia

DOI: 10.1016/j.jalz.2017.06.141

Authors: Andy Billinton, Phil Newton, Chris Lloyd, Maria Groves, Fraser Welsh, Anna Bogstedt, Susanna Eketjall, Mary McFarlane, Michael Perkinton, Rajesh Narwal, Keith Tan, Amanda Dudley, Tristan Vaughan, Iain Chessell

Institutions: AstraZeneca (United Kingdom), AstraZeneca (Sweden)

Language: English

Topic: Alzheimer's disease research and treatments

Subfield: Physiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2766914504

FWCI: 1.617

Cites:

Cited by: 12

Related to: 10